2940 summary statistics; Europeans; both GRCh19/38
1391 summary statistics; Finnish men; GRCh38; tsv files
249 summary statistics; Europeans; GRCh37; vcf files
Don’t have a breakdown by class, but do know the files include:
I haven’t yet added CHD to the analysis, nor have I formatted the data. I’m waiting to finish benchmarking proteins and metabolites. But the plan is to add in CHD and other clinical phenotypes.
The CHD data below was done on the CARDIoGRAMplusC4D chip, which included Europeans and South Asians. (The authors of Hyprcoloc used it while saying that their method relies on the traits in the model being from the same population! Begs some questions in the colloquial sense [vs petitio principii], such as: “Which is it? Can Hyprcoloc handle traits from different ancestries or not?” “Was it on oversight or on purpose?”)
In the R documentation for Hyprcoloc, LD matrices aren’t required. This is because the authors assume the traits don’t overlap. There are options for indicating the traits do overlap, but the analysis gets vastly more complex. We need three additional matrices if samples overlap. So, it is best to choose wisely from the beginning, at least initally.
UKP-PPP, METSIM, and CHD CARDIoGRAMplusC4D should be reasonably independent. (I may need to change course on the UKB Nightingale idea. There are Nightingale summary statistics that contain fewer people that aren’t from the UKB. I might be able to get them instead of the ones I downloaded. METSIM is the priority, now.)
| Phenotype | Abbreviation | Dataset | Author | PubMed ID | Sample Size (N) | Number of Cases (N Cases) | Population |
|---|---|---|---|---|---|---|---|
| Coronary Heart Disease | CHD | ieu-a-7 | Nikpay | 26343387 | 184,305 | 60,801 | Mixed |
NOTE: Remember the Jurgens data…
Main: /Users/charleenadams/coloc_clin_mol
UKB-PPP files:
METSIM files: /Users/charleenadams/metsim_files
Nightingale files: /Users/charleenadams/met_d_files
Selected clinical phenotype files: /Users/charleenadams/clinical_files
I had previously obtained these (see https://rpubs.com/YodaMendel/1243451) for an example of how to programmatically get files from UKB-PPP.
caffeinate -i ./add_rsids.shTakes too long; keep as chromosomes; retained because it likely works and we might need the chromosomes merged if we try out a non-cis-region approach later.
The method I devised below obtains cis-regions (500KB up and downstream of TSSes using Ensembl) for 2808 of 2940 (96%) of the files.
Adding in the rsIDs created headers with mixed delimiters, so I fixed that.
We conducted a colocalization analysis using HyPrColoc to explore shared genetic loci influencing PCSK9 and 184 METSIM metabolites.
top = 10 metabolites containing rsIDs with smallest p-values
Here I provide James Staley’s (Hyprcoloc package author) example results. Their paper for the package had examined CHD. Their top putatively causal SNP (rs11591147) is the same as ours:
| Iteration | Traits | Posterior Probability | Regional Probability | Candidate SNP | Posterior Explained by SNP | Dropped Trait |
|---|---|---|---|---|---|---|
| 1 | T1, T2, T3, T4, T5 | 1.0000 | 1 | rs11591147 | 1.0000 | NA |
| 2 | T6, T7, T8 | 0.9164 | 1 | rs12117612 | 0.4197 | NA |
| 3 | T9, T10 | 0.9018 | 1 | rs7524677 | 0.0763 | NA |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1,2-dipalmitoyl-GPC (16:0/16:0), 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1), 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), 1-palmitoyl-2-stearoyl-GPC (16:0/18:0), 1-palmityl-2-palmitoyl-GPC (O-16:0/16:0), 1-stearoyl-2-oleoyl-GPI (18:0/18:1), 1-stearoyl-GPC (18:0), N-palmitoyl-sphingosine (d18:1/16:0), PCSK9, X - 23641, arachidoylcarnitine (C20), behenoyl sphingomyelin (d18:1/22:0), cerotoylcarnitine (C26), cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl ceramide (d18:2/24:1, d18:1/24:2), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), lactosyl-N-nervonoyl-sphingosine (d18:1/24:1), lignoceroyl sphingomyelin (d18:1/24:0), myristoyl dihydrosphingomyelin (d18:0/14:0), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0), sphingomyelin (d18:0/20:0, d16:0/22:0), sphingomyelin (d18:1/20:0, d16:1/22:0), sphingomyelin (d18:1/24:1, d18:2/24:0), sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0), sphingomyelin (d18:2/16:0, d18:1/16:1) | 0.4593 | 0.6101 | rs11591147 | 1 |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1,2-dipalmitoyl-GPC (16:0/16:0), 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1), 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), 1-palmitoyl-2-stearoyl-GPC (16:0/18:0), 1-palmityl-2-palmitoyl-GPC (O-16:0/16:0), 1-stearoyl-2-oleoyl-GPI (18:0/18:1), 1-stearoyl-GPC (18:0), N-palmitoyl-sphingosine (d18:1/16:0), PCSK9, X - 23641, arachidoylcarnitine (C20), behenoyl sphingomyelin (d18:1/22:0), cerotoylcarnitine (C26), cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl ceramide (d18:2/24:1, d18:1/24:2), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), lactosyl-N-nervonoyl-sphingosine (d18:1/24:1), lignoceroyl sphingomyelin (d18:1/24:0), myristoyl dihydrosphingomyelin (d18:0/14:0), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0), sphingomyelin (d18:0/20:0, d16:0/22:0), sphingomyelin (d18:1/20:0, d16:1/22:0), sphingomyelin (d18:1/24:1, d18:2/24:0), sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0), sphingomyelin (d18:2/16:0, d18:1/16:1) | 0.7712 | 0.7792 | rs11591147 | 1 |
| 2 | (S)-3-hydroxybutyrylcarnitine, 3-hydroxydecanoate, 3-hydroxydecanoylcarnitine, 3-hydroxyhexanoate, 3-hydroxylaurate, 3-hydroxyoctanoate, X - 15469, X - 16397, X - 18921, X - 21353, X - 22519, cis-4-decenoate (10:1n6), dodecadienoate (12:2), tetradecadienoate (14:2) | 0.7638 | 0.7864 | rs1616691 | 1 |
| 3 | 2,3-dihydroxy-5-methylthio-4-pentenoate (DMTPA), 2-palmitoyl-GPE (16:0), X - 15503, adipoylcarnitine (C6-DC), dimethylarginine (SDMA + ADMA), kynurenine, pseudouridine | 0.7604 | 0.7791 | rs141072298 | 0.8198 |
| 4 | N-acetylkynurenine (2), cis-4-decenoylcarnitine (C10:1), decanoylcarnitine (C10), hexanoylcarnitine (C6), octanoylcarnitine (C8) | 0.8019 | 0.8254 | rs148238018 | 0.9829 |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1,2-dipalmitoyl-GPC (16:0/16:0), 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1), 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), 1-palmitoyl-2-stearoyl-GPC (16:0/18:0), 1-palmityl-2-palmitoyl-GPC (O-16:0/16:0), N-palmitoyl-sphingosine (d18:1/16:0), PCSK9, behenoyl sphingomyelin (d18:1/22:0), cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl ceramide (d18:2/24:1, d18:1/24:2), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), lactosyl-N-nervonoyl-sphingosine (d18:1/24:1), lignoceroyl sphingomyelin (d18:1/24:0), myristoyl dihydrosphingomyelin (d18:0/14:0), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0), sphingomyelin (d18:0/20:0, d16:0/22:0), sphingomyelin (d18:1/20:0, d16:1/22:0), sphingomyelin (d18:1/24:1, d18:2/24:0), sphingomyelin (d18:2/16:0, d18:1/16:1) | 0.9687 | 0.9808 | rs11591147 | 1 |
| 2 | (S)-3-hydroxybutyrylcarnitine, 3-hydroxydecanoate, 3-hydroxydecanoylcarnitine, 3-hydroxyhexanoate, 3-hydroxylaurate, 3-hydroxyoctanoate, X - 15469, X - 21353, X - 22519 | 0.9832 | 0.9884 | rs1616691 | 1 |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), PCSK9, cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d18:1/24:1, d18:2/24:0) | 0.9994 | 1 | rs11591147 | 1 |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), PCSK9, cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d18:1/24:1, d18:2/24:0) | 1 | 1 | rs11591147 | 1 |
| Iteration | Traits | Posterior Prob | Regional Prob | Candidate SNP | Posterior Explained by SNP |
|---|---|---|---|---|---|
| 1 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0), PCSK9, cholesterol, glycosyl ceramide (d18:1/20:0, d16:1/22:0), glycosyl-N-palmitoyl-sphingosine (d18:1/16:0), hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)), palmitoyl dihydrosphingomyelin (d18:0/16:0), palmitoyl sphingomyelin (d18:1/16:0), palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0), sphingomyelin (d18:1/24:1, d18:2/24:0) | 0.9994 | 1 | rs11591147 | 1 |